HSBC Reiterates “€57.00” Price Target for Fielmann (FIE)

HSBC set a €57.00 ($64.77) target price on Fielmann (FRA:FIE) in a research report released on Monday morning. The firm currently has a neutral rating on the stock.

Several other equities analysts have also commented on FIE. Nord/LB set a €85.00 ($96.59) price objective on shares of Fielmann and gave the stock a buy rating in a report on Tuesday, April 17th. DZ Bank restated a neutral rating on shares of Fielmann in a report on Wednesday, April 18th. Baader Bank set a €76.00 ($86.36) price objective on shares of Fielmann and gave the stock a buy rating in a report on Thursday, April 26th. equinet set a €70.00 ($79.55) price objective on shares of Fielmann and gave the stock a neutral rating in a report on Thursday, April 26th. Finally, Independent Research set a €70.00 ($79.55) price objective on shares of Fielmann and gave the stock a neutral rating in a report on Thursday, April 26th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of Hold and an average target price of €62.71 ($71.27).

Shares of FIE stock opened at €59.30 ($67.39) on Monday. Fielmann has a one year low of €65.50 ($74.43) and a one year high of €77.50 ($88.07).

Fielmann Company Profile

Fielmann Aktiengesellschaft invests in and operates optical and hearing aid businesses in Germany, Switzerland, Austria, and internationally. The company designs, manufactures, distributes, and retails visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses, and related articles and accessories, as well as hearing aids and accessories.

Read More: How to Invest in Growth Stocks

Analyst Recommendations for Fielmann (FRA:FIE)

Receive News & Ratings for Fielmann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fielmann and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply